Suppr超能文献

[利用声动力疗法诱导的细胞焦亡进行肝癌治疗]

[Utilizing Sonodynamic Therapy-Induced Pyroptosis for Liver Cancer Therapy].

作者信息

Zhang Nisi, Dai Zhifei

机构信息

( 100871) Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing 100871, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1329-1335. doi: 10.12182/20240960210.

Abstract

Liver cancer is one of the leading causes of cancer-related deaths worldwide. However, all liver cancer treatment options currently available fail to achieve a complete cure. Recently, research on pyroptosis has attracted significant attention from researchers in the field of cancer therapy. Pyroptosis is an inflammatory cell death closely related to oxidative stress caused by reactive oxygen species (ROS). The induction of pyroptosis can lead to the inhibition of tumor proliferation and the improvement of tumor immune responsiveness and is considered a novel therapeutic mechanism that can be utilized to develop new cancer therapies. Sonodynamic therapy (SDT), which involves a synergistic application of sonosensitizers and low-intensity focused ultrasound to generate cytotoxic ROS, demonstrates certain advantages and potentials in the treatment of liver cancer. However, liver cancer treatment utilizing SDT is still in the stage of preclinical research, and the specific conditions of ultrasound treatment, the biological effects, and the mechanisms of action are not fully understood. In this review, we discussed the potential of utilizing pyroptosis in liver cancer treatment, the mechanism of cancer therapy with ROS generated by SDT, and the latest findings concerning SDT from clinical and basic research. We discussed the utilization of SDT to force the accumulation of ROS in tumors to exceed the cytotoxicity threshold. Thus, SDT promotes pyroptosis and enhances the immune response to cancer. Furthermore, we discussed the prospects for applying the mechanism of SDT-induced pyroptosis in cancer therapy, thereby providing a better theoretical and experimental foundation for the clinical translation of SDT for liver cancer treatment.

摘要

肝癌是全球癌症相关死亡的主要原因之一。然而,目前所有可用的肝癌治疗方案都无法实现完全治愈。最近,细胞焦亡的研究引起了癌症治疗领域研究人员的极大关注。细胞焦亡是一种与活性氧(ROS)引起的氧化应激密切相关的炎症性细胞死亡。诱导细胞焦亡可导致肿瘤增殖受到抑制,肿瘤免疫反应性得到改善,被认为是一种可用于开发新癌症治疗方法的新型治疗机制。声动力疗法(SDT)涉及协同应用声敏剂和低强度聚焦超声以产生活性细胞毒性ROS,在肝癌治疗中显示出一定的优势和潜力。然而,利用SDT进行肝癌治疗仍处于临床前研究阶段,超声治疗的具体条件、生物学效应和作用机制尚未完全了解。在这篇综述中,我们讨论了在肝癌治疗中利用细胞焦亡的潜力、SDT产生的ROS进行癌症治疗的机制以及来自临床和基础研究的关于SDT的最新发现。我们讨论了利用SDT促使肿瘤中ROS的积累超过细胞毒性阈值。因此,SDT促进细胞焦亡并增强对癌症的免疫反应。此外,我们讨论了将SDT诱导细胞焦亡的机制应用于癌症治疗的前景,从而为SDT用于肝癌治疗的临床转化提供更好的理论和实验基础。

相似文献

1
[Utilizing Sonodynamic Therapy-Induced Pyroptosis for Liver Cancer Therapy].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1329-1335. doi: 10.12182/20240960210.
4
Biodegradable pyroptosis inducer with multienzyme-mimic activity kicks up reactive oxygen species storm for sensitizing immunotherapy.
J Control Release. 2024 Jun;370:438-452. doi: 10.1016/j.jconrel.2024.04.054. Epub 2024 May 6.
5
Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.
Adv Sci (Weinh). 2023 Jan;10(2):e2204365. doi: 10.1002/advs.202204365. Epub 2022 Nov 27.
7
Titanium-Based Nanoarchitectures for Sonodynamic Therapy-Involved Multimodal Treatments.
Small. 2023 Mar;19(12):e2206253. doi: 10.1002/smll.202206253. Epub 2023 Jan 15.
8
Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy.
Front Bioeng Biotechnol. 2021 Sep 30;9:761218. doi: 10.3389/fbioe.2021.761218. eCollection 2021.
10
Recent Developments of Inorganic Nanosensitizers for Sonodynamic Therapy.
Adv Healthc Mater. 2023 Sep;12(22):e2300234. doi: 10.1002/adhm.202300234. Epub 2023 May 1.

本文引用的文献

2
Sonodynamic therapy for the treatment of atherosclerosis.
J Pharm Anal. 2024 May;14(5):100909. doi: 10.1016/j.jpha.2023.11.016. Epub 2023 Nov 29.
3
IR-820@NBs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy.
Int J Nanomedicine. 2023 Nov 1;18:6199-6212. doi: 10.2147/IJN.S431910. eCollection 2023.
6
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
7
Nanobubble-based anti-hepatocellular carcinoma therapy combining immune check inhibitors and sonodynamic therapy.
Nanoscale Adv. 2022 Sep 30;4(22):4847-4862. doi: 10.1039/d2na00322h. eCollection 2022 Nov 8.
8
Smart NIR-II croconaine dye-peptide for enhanced photo-sonotheranostics of hepatocellular carcinoma.
Theranostics. 2022 Jan 1;12(1):76-86. doi: 10.7150/thno.64759. eCollection 2022.
9
Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma.
ACS Cent Sci. 2021 Dec 22;7(12):2049-2062. doi: 10.1021/acscentsci.1c01143. Epub 2021 Dec 8.
10
Intracranial Sonodynamic Therapy With 5-Aminolevulinic Acid and Sodium Fluorescein: Safety Study in a Porcine Model.
Front Oncol. 2021 Jun 21;11:679989. doi: 10.3389/fonc.2021.679989. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验